Illumina has made several management changes in the wake of its acquisition of Solexa last week (see related article, this issue). John West, the former CEO of Solexa, has joined Illumina as senior vice president and general manager of the sequencing business. John Stuelpnagel, Illumina’s COO, will now also serve as general manager of the company’s microarray business. Tristan Orpin, Illumina’s vice president of sales, has been promoted to senior vice president in charge of all commercial operations. Christian Henry, vice president and CFO, has been promoted to senior vice president and CFO and has assumed the additional responsibility of investor relations. Matt Posard, vice president of marketing, is now vice president of sales, while Omead Ostadan, formerly vice president of marketing at Solexa, will replace Posard as vice president of marketing at Illumina. In addition, Blaine Bowman and Roy Whitfield have joined Illumina’s board of directors from Solexa’s board of directors.
Gene Myers has joined the scientific advisory board of Helicos BioSciences. He is a group leader at the Howard Hughes Medical Institute’s Janelia Farm Research Campus in Ashburn, Va. Myers has played a role in the development of Blast and Celera Genomics’ whole-genome sequence assembler and is currently focused on the development of algorithms and software for image analysis.
“As Helicos continues its rapid growth, we recognize the need to continue to build a bioinformatics capability designed to fully support our efforts,” said Stanley Lapidus, president and CEO of Helicos, in a statement.
Myers joined the scientific advisory board of 454 Life Sciences in 2003.
Sequenom has hired Steven Owings as vice president of commercial development, prenatal diagnostics, a new position for the company. Owings will lead commercialization efforts for the company’s non-invasive prenatal diagnostic technology. Owings held various managerial and sales positions at Roche Diagnostic Systems, including director of the company’s PCR business unit from 1992 to 1997. He also served as vice president of sales and marketing at Digene and as vice president of sales and marketing for Visible Genetics, which was purchased by Bayer Diagnostics in 2002. Most recently, he served as president, North America, of Primagen. Owings holds a BS from Northern Arizona University.
The Bioinformatics Organization has announced its nominees for the 2007 Benjamin Franklin Award in Bioinformatics, which is presented annually by the members of the non-profit open source bioinformatics advocacy group "to an individual who has worked to promote open access to the materials and methods used in the field." This year’s nominees are: Sean Eddy, group leader at the Howard Hughes Medical Institute Janelia Farm Research Campus; Robert Gentleman, head of the program in computational biology, division of public health sciences, Fred Hutchinson Cancer Research Center; Don Gilbert, director of the Genome Informatics Lab, Indiana University, Bloomington; and Steven Salzberg, director of the Center for Bioinformatics and Computational Biology, University of Maryland, College Park.
Deirdre Meldrum has been tapped to head the new Center for EcoGenomics at Arizona State University’s Biodesign Institute. Meldrum will oversee the Microscale Life Sciences Center, which is a National Institutes of Health Center of Excellence in Genomic Science, as well as an oceanography project called NEPTUNE. In 1996, Meldrum was awarded a Presidential Early Career Award for Scientists and Engineers “for recognition of innovative research utilizing a broad set of interdisciplinary approaches to advance DNA sequencing technology.” She received a PhD in electrical engineering from StanfordUniversity, a master’s degree in electrical engineering from Rensselaer Polytechnic Institute, and a bachelor’s of science degree in civil engineering from the University of Washington.